Global Breast Lesion Localization Methods Market– Breakthrough in Breast Cancer Diagnosis
Breast cancer is a disease in which cells in the breast grow abnormally, in order to form a lump, which may be a malignant or non-malignant in nature. Such cells usually form tumors that can often be observed on an x-ray or felt as a lump. Growing prevalence of breast cancer, increasing awareness for treatment, presence of favorable reimbursement policy in developed and emerging economies, and increasing product development are expected to drive growth of the breast lesion localization methods market.
The global breast lesion localization methods market size was valued at US$ 530.2 million in 2018 and is expected to exhibit a CAGR of 10.7% over the forecast period (2019–2027).
To Gain More Insights into the Breast Lesion Localization Methods Market, Browse Summary of the Research Report – https://www.coherentmarketinsights.com/market-insight/breast-lesion-localization-methods-market-104
Market Dynamics- Drivers
Increasing incidence and prevalence of breast cancer worldwide to fuel the global breast lesion localization methods market
Increasing prevalence of breast cancer in developed and emerging economies is expected to drive growth of the global breast lesion localization methods market over the forecast period. According to Breastcancer.org, in 2019, in the U.S., around 268,600 cases of invasive breast cancer are expected to be diagnosed along with over 62,930 cases of non-invasive breast cancer. This, in turn, is expected to propel the global breast lesion localization methods market growth during the forecast period.
Moreover, significant rise in population in emerging economies such as India and increasing focus towards strengthening healthcare infrastructure are expected to drive growth of the global breast lesion localization methods market in the near future. For instance, according to The Pink Initiative and Breast Cancer Statistics in India, breast cancer is the most common cancer in most cities in India and second most common in the rural areas, and accounts for 25% to 32% of all female cancers.
“We Do Offer Sample of this report. Kindly go through the follow information in order to access the report.”
Note- This report sample includes:
– Brief Introduction to the research report.
– Table of Contents (Scope covered as a part of the study)
– Top players in the market
– Research framework (structure of the report)
– Research methodology adopted by Coherent Market Insights
Request A Sample Copy – Breast Lesion Localization Methods Market Report Click here: https://www.coherentmarketinsights.com/insight/request-sample/104
Key players operating in the market are focused towards development of new products to expand their product portfolio, which in turn is expected to propel the market growth over the forecast period. For instance, in January 2019, the U.S. Food and Drug Administration (FDA) approved Hologic Inc.’s radiofrequency identification (RFID) breast lesion localization device for long-term placement.
Increasing adoption of expansion strategies by major players operating in the market is expected to fuel growth of the breast lesion localization methods market
Key players in the market are involved in various growth strategies such as mergers, agreement, and acquisition, in order to enhance their market presence. For instance, in July 2018, Hologic Inc. and SOMATEX Medical Technologies GmbH entered into a distribution agreement. According to the agreement, Hologic Inc. will have distribution rights for SOMATEX Tumark biopsy site markers, in the U.S.
Note: Access insightful study with over 150+ pages, list of tables & figures, profiling 20+ companies.
Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/104
Moreover, increasing product launches is also expected to propel growth of the global breast lesion localization methods market during the forecast period. Manufacturers are expanding their product portfolio by introducing new and advanced products. For instance, in August 2018, SOMATEX Medical Technologies GmbH launched Tumark Eye, an innovative clip marking system for breast cancer with high ultrasound visibility.
Key Players
Major players operating in the global breast lesion localization methods market include Cook Medical Inc., Argon Medical Devices, Inc., Becton, Dickinson and Company (C. R. Bard), SOMATEX Medical Technologies GmbH, Sterylab Medical, Biopsybell Srl, Hologic Inc., and Tsunami S.r.l.
Browse Press Release: http://bit.ly/2qCGyAZ
Detailed Segmentation:
- Global Breast Lesion Localization Methods Market, By Technique:
- Wire Guided Localization
- Radio Guided Occult Lesion Localization
- Radioactive Seed Localization
- Magnetic Tracers
- Ultrasound Guided Surgery
- Global Breast Lesion Localization Methods Market, By End User:
- Hospitals
- Specialized Clinics
- Research Institutes
- Ambulatory Surgical Centers
- Global Breast Lesion Localization Methods Market, By Region:
- North America
- By Technique:
- Wire Guided Localization
- Radio Guided Occult Lesion Localization
- Radioactive Seed Localization
- Magnetic Tracers
- Ultrasound Guided Surgery
- By End User:
- Hospitals
- Specialized Clinics
- Research Institutes
- Ambulatory Surgical Centers
- By Country:
- U.S.
- Canada
- By Technique:
- Latin America
- By Technique:
- By End User:
- By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Technique:
- By End User:
- By Country:
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- By Technique:
- By End User:
- By Country:
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- By Technique:
- By End User:
- By Country:
- GCC
- Israel
- Rest of Middle East
- Africa
- By Technique:
- By End User:
- By Country/Region:
- South Africa
- Central Africa
- North Africa
- North America
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
